Gambling and increased sexual desire with dopaminergic medications in restless legs syndrome.

Gambling and increased sexual desire with dopaminergic medications in restless legs syndrome. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Gambling and increased sexual desire with dopaminergic medications in restless legs syndrome. Abstract Text:

Erika D Driver-Dunckley,Brie N Noble,Joseph G Hentz,Virgilio G H Evidente,John N Caviness,James Parish,Lois Krahn,Charles H Adler,Erika D Driver-Dunckley,Brie N Noble,Joseph G Hentz,Virgilio G H Evidente,John N Caviness,James Parish,Lois Krahn,Charles H Adler,

OBJECTIVES: Do patients with restless legs syndrome (RLS) report gambling or other abnormal behaviors as previously reported in Parkinson disease. METHODS: This survey study was sent to 261 idiopathic RLS patients, and it included the Gambling Symptoms Assessment Scale, Altman Self-Rating Mania Scale, and questions pertaining to sexual activity and novelty-seeking behaviors. RESULTS: Ninety-nine patients responded to the survey, and 77 were actively taking 1 or more dopaminergic medications. Of the 70 respondents who answered the gambling questions, 5 (7%) noted a change in gambling, with 4 (6%; 95% confidence interval, 2%-14%) stating that increased urges and time spent gambling occurred specifically after the use of dopaminergic medications (2 on pramipexole, 1 on ropinirole, and 1 on levodopa and pramipexole). Increased sexual desire was reported by 4 (5%) of the 77 respondents, 3 (4%; 95% confidence interval, 1%-11%) reported that this occurred specifically after the use of dopaminergic medications (1 on pramipexole, 1 on ropinirole, and 1 on levodopa). One patient reported both an increase in gambling and sexual habits. CONCLUSIONS: This exploratory survey study revealed the development of gambling and/or increased sexuality in patients with RLS. These data raise the possibility that, as in Parkinson disease, RLS patients should be cautioned about potential behaviors that may occur with the use of dopaminergic medications. Further prospective studies are needed to assess the relationship between these medications and compulsive behaviors associated with the treatment of RLS.

Gambling and increased sexual desire with dopaminergic medications in restless legs syndrome. Publishing Authors By Initials

ED Driver-Dunckley,BN Noble,JG Hentz,VG Evidente,JN Caviness,J Parish,L Krahn,CH Adler,ED Driver-Dunckley,BN Noble,JG Hentz,VG Evidente,JN Caviness,J Parish,L Krahn,CH Adler,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Gambling and increased sexual desire with dopaminergic medications in restless legs syndrome. Journal Published:

PUBLICATION TYPE: Research Support, Non-U.S. Gov

Journal: Clinical neuropharmacology

VOLUME: 30

Page Numbers: 249-55

Journal Abbreviation:

ISSN: 0362-5664

DAY: 2

MONTH: 10

YEAR: 2007

Gambling and increased sexual desire with dopaminergic medications in restless legs syndrome. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 7607910

Gambling and increased sexual desire with dopaminergic medications in restless legs syndrome. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Gambling and increased sexual desire with dopaminergic medications in restless legs syndrome. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Gambling and increased sexual desire with dopaminergic medications in restless legs syndrome.

AFFILIATION: Department of Neurology, Parkinson's Disease and Movement Disorders Center, Mayo Clinic, 13400 E. Shea Boulevard, Scottsdale, AZ 85259, USA. driverdunckley.erika@mayo.edu

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Clin Neuropharmacol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Gambling and increased sexual desire with dopaminergic medications in restless legs syndrome Related Publications

• Anandamide and Delta9-tetrahydrocannabinol directly inhibit cells of the immune system via CB2 receptors.
• Beneficial effects of eplerenone versus hydrochlorothiazide on coronary circulatory function in patients with diabetes mellitus.
• Both early and late cognitive dysfunction affects the electroencephalogram in Parkinson's disease.
• Cancer treatment-induced bone loss.
• Cross-sectional analysis of specific complementary and alternative medicine (CAM) use by racial/ethnic group and menopausal status: the Study of Women's Health Across the Nation (SWAN).
• Cutaneous necrotizing vasculitis associated with hepatitis C virus infection.
• Defining mild cognitive impairment in Parkinson's disease.
• Dendritic cells program non-immunogenic prostate-specific T cell responses beginning at early stages of prostate tumorigenesis.
• Effective permeability of fractured porous media with power-law distribution of fracture sizes.
• Effects of follistatin overexpression on cell differentiation in the chick embryo retina.
• Effects of temperature on gene expression patterns in Leptospira interrogans serovar Lai as assessed by whole-genome microarrays.
• Enhanced expression of mucin genes in a guinea pig model of allergic asthma.
• Estradiol increases proteinuria and angiotensin II type 1 receptor in kidneys of rats receiving L-NAME and angiotensin II.
• Functional ability correlates with cognitive impairment in Parkinson's disease and Alzheimer's disease.
• Gambling and increased sexual desire with dopaminergic medications in restless legs syndrome.
• Histone acetylation at the Ifng promoter in tolerized CD4 cells is associated with increased IFN-gamma expression during subsequent immunization to the same antigen.
• Influence of the Stern layer on electrokinetic phenomena in porous media.
• Marked microglial reaction in normal aging human substantia nigra: correlation with extraneuronal neuromelanin pigment deposits.
• Mechanisms of T cell tolerance and suppression in cancer mediated by tumor-associated antigens and hormones.
• Mineralocorticoid receptor antagonist reduces renal injury in rodent models of types 1 and 2 diabetes mellitus.
• Nociceptin/orphanin FQ blocks the antinociception induced by mu, kappa and delta opioid agonists on the cold water tail-flick test.
• Perceived socioeconomic status: a new type of identity that influences adolescents' self-rated health.
• Pollinator and herbivore attraction to cucurbita floral volatiles.
• Steady state dendritic cells present parenchymal self-antigen and contribute to, but are not essential for, tolerization of naive and Th1 effector CD4 cells.
• Teaching resources. A biochemical assay for acetylcholinesterase activity in PC12 cells.
• The application of the HapMap to diabetic nephropathy and other causes of chronic renal failure.
• The chemokine CX3CL1/fractalkine interferes with the antinociceptive effect induced by opioid agonists in the periaqueductal grey of rats.
• The flare gene, which encodes the AIP1 protein of Drosophila, functions to regulate F-actin disassembly in pupal epidermal cells.
• Treatment of cavernous sinus tumors with linear accelerator radiosurgery.
• [Potential therapy for mucus hypersecretion in chronic obstructive pulmonary disease]